WNT10A and diffuse large B-cell lymphoma: Analyzing WNT10A expression in The Cancer Genome Atlas (TCGA) database indicated that elevated WNT10A expression in DLBCL patients was concerned with advanced clinical stages (III and IV) (Figure 4F).